Fuereder, Thorsten http://orcid.org/0000-0001-5356-6452
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 10 June 2023
Accepted: 10 July 2023
First Online: 18 August 2023
Conflict of interest
: T. Fuereder is member of advisory boards and/or received honoraria from MSD, Merck, Roche, Novartis, Amgen, Pfizer, BMS and Boehringer Ingelheim, Takeda and Janssen, Invios. Research funding by MSD and Merck.